Trial · NCT07908095
The Impact of Continuous Case Support and Resource Provision in Clinical Social Work Interventions
NCT07908095, Recruiting, Andrea Zumbrunn
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Impact of Continuous Case Support and Resource Provision in Clinical Social Work Interventions. Trials, record NCT07908095. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908095
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Impact of Continuous Case Support and Resource Provision in Clinical Social Work Interventions
- NCT number
- NCT07908095
- Status
- Recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Andrea Zumbrunn
- Conditions
- Psychosocial Problems, Social Support Needs, Chronic Illness
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change of perceived stress and burden (PSS) from baseline to 3 and 6 months | At baseline (initiation of support), and at 3 and 6 months | Perceived Stress Scale PSS Subscale Perceived Helplessness: 6 items (items 1, 2, 3, 6, 9, 10); Each item scored 0-4 → range: 0-24; Higher scores = greater feelings of lack of control over circumstances or emotions Subscale Perceived Self-Efficacy: 4 items (items 4, 5, 7, 8); Each item scored 0-4 → range: 0-16; Higher scores = greater perceived inability to handle problems (i.e., lower self-efficacy) |
| Primary | Change of self-determined live conduct through the assessment of capabilities (OxCAP) from baseline to 3 and to 6 months | At baseline (initiation of support), and at 3 and 6 months | OxCAP-MH Oxford CAPabilities questionnaire for Mental Health: Raw score range: 16-80 (16 items, each scored 1-5), standardized to 0-100; Higher scores = higher level of capabilities/quality of life; in our study Item-level analysis |
| Primary | Change of navigation of and knowledge about the support system (self-developed items) from baseline to 3 and to 6 months | At baseline (initiation of support), and at 3 and 6 months | Self-constructed items, inspired by DSS - Discontinuation Success Scale, I am able to navigate the support system (disability insurance, accident insurance, physicians, etc.) well./ I know where to turn to get the right support when I need it. Rated on a 5-point Likert scale (1 = does not apply to 5 = fully applies) |
| Primary | Change of self-determined live conduct through the assessment of social participation (F-SozU) from baseline to 3 and to 6 months | At baseline (initiation of support), and at 3 and 6 months | F-SozU - Social Integration scale (SI): 13 items (long form S-54); Rated on a 5-point Likert scale (1 = does not apply to 5 = fully applies); Range: 13-65 (or 1-5 when using the mean score); Content: belonging to a circle of friends, engaging in joint activities, knowing people with similar interests/values; Higher scores = greater social integration |
| Secondary | Change of hope for improvement (FPTM) in one's condition from baseline to 3 and to 6 month | At baseline (initiation of support), and at 3 and 6 months | FPTM - Questionnaire for Psychotherapy Motivation - Hope scale (HO): Original version (FPTM-39): 7 items, 4-point response format (1-4) → Range: 7-28; Higher scores = greater confidence/optimism regarding improvement through treatment (interpreted positively, indicating higher therapy motivation); in our study item-level analysis |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908095
GET https://conductscience.org/api/trials/v1/NCT07908095/registered